I've lost a stack on this and am prepared to average down based on promising results.
However, I'm concerned about the cost of Phase III and how this will be funnded given such a low market cap. Its appears that current cash balances are being allocated to other trials and operating costs.
Does anybody have any insight or are we waiting for clarification at the AGM?
The GREENFUND - we're buying the dip, big time, and here's why., page-50
-
- There are more pages in this discussion • 110 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.005(1.39%) |
Mkt cap ! $645.1M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $1.731M | 4.833M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 105638 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 215555 | 4 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |